Lifespan Brain Institute, Penn Medicine and Children's Hospital of Philadelphia, the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, and the Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Lifespan Brain Institute, Penn Medicine and Children's Hospital of Philadelphia, the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, and the Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Curr Opin Genet Dev. 2021 Jun;68:35-40. doi: 10.1016/j.gde.2021.01.007. Epub 2021 Feb 8.
The 22q11.2 Deletion Syndrome has significant impact on brain and behavior, with about 25% of individuals developing schizophrenia. The condition offers a model for prospective studies on the emergence of psychosis and advancing mechanistic hypotheses on gene-environment interactions, with magnified power for examining genome-phenome association. Here, we highlight findings that build on the International 22q11.2 Brain and Behavior Consortium and relate to several key domains in the study of psychosis-risk and schizophrenia. We examine neurocognition, olfaction and neuroimaging data that indicate similar impairment patterns in this rare syndrome and idiopathic presentation of schizophrenia. We conclude that the converging paradigms, studying psychosis dimensionally in rare and common variants samples, provide complementary approaches that will propel precision medicine in psychiatry.
22q11.2 缺失综合征对大脑和行为有重大影响,约 25%的个体发展为精神分裂症。该病症为前瞻性研究精神病的出现以及推进基因-环境相互作用的机制假说提供了模型,具有增强的基因组-表型关联检验能力。在这里,我们重点介绍了基于国际 22q11.2 大脑与行为联盟的研究结果,并与精神病风险和精神分裂症研究的几个关键领域相关。我们检查了神经认知、嗅觉和神经影像学数据,这些数据表明在这种罕见的综合征和特发性精神分裂症中存在相似的损伤模式。我们的结论是,在罕见和常见变异样本中从多维角度研究精神病的趋同范式为精神病学的精准医学提供了互补的方法。